BioNxt Solutions (BNXTF) News Today → Gold Mania (From Stansberry Research) (Ad) Free BNXTF Stock Alerts $0.30 0.00 (0.00%) (As of 05/3/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartEarningsHeadlinesShort InterestStock AnalysisChartEarningsHeadlinesShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineBioNxt Solutions Inc.: BioNxt Solutions Announces ODF Cladribine Update and Financingfinanznachrichten.de - April 26 at 2:00 AMBioNxt Solutions Inc.: BioNxt Reports Commercialization of ODF Cladribine Product for MS Next Stepsfinanznachrichten.de - March 18 at 4:56 AMBioNxt Solutions Inc.: BioNxt Reports Successful Results From ODF Cladribine PK Studyfinanznachrichten.de - March 13 at 3:50 AMBioNxt Solutions Inc.: BioNxt Reports Completion of ODF Cladribine PK Studyfinanznachrichten.de - March 4 at 7:35 AMBioNxt Solutions finalizes debt settlement agreementmsn.com - February 19 at 8:50 AMBioNxt Solutions Finalizes Agreementfinance.yahoo.com - February 16 at 9:22 PMBioNxt Solutions Inc.: BioNxt Reports Successful Results From ODF Cladribine Toxicity Studyfinanznachrichten.de - February 7 at 1:11 PMBioNxt Reports Successful Results From ODF Cladribine Toxicity Studyfinance.yahoo.com - February 7 at 1:11 PMBioNxt Solutions Inc.: BioNxt Solutions Announces Closing of Final Tranche of Non-Brokered Private Placementfinanznachrichten.de - January 30 at 6:24 AMBioNxt Solutions Announces Closing of Final Tranche of Non-Brokered Private Placementfinance.yahoo.com - January 30 at 6:24 AMBioNxt Solutions Inc. (BNXT.CN)ca.finance.yahoo.com - January 5 at 9:34 PMBioNxt Solutions Inc.: BioNxt Solutions Announces Completion of Cladribine ODF Toxicity Study and Financingfinanznachrichten.de - December 23 at 9:02 AMBioNxt Solutions Announces Completion of Cladribine ODF Toxicity Study and Financingfinance.yahoo.com - December 21 at 8:42 PMBioNxt Receives Delivery of Premium Commercial Coating and Cutting Equipment for Commercial Manufacturing of Drug Delivery Productsfinance.yahoo.com - December 12 at 8:52 AMBioNxt Solutions Announces Completion of Debenture and Interest Settlement and Issuance of Finder’s Warrantsfinance.yahoo.com - December 9 at 12:12 AMBionxt Solutions Announces Convertible Debenture and Interest Settlementbenzinga.com - November 24 at 9:32 PMBioNxt Solutions Inc.: BioNxt Accelerates Cladribine ODF Clinical and Commercialization Strategy for Multiple Sclerosis Treamentfinanznachrichten.de - November 20 at 9:05 AMBioNxt Accelerates Cladribine ODF Clinical and Commercialization Strategy for Multiple Sclerosis Treamentfinance.yahoo.com - November 20 at 9:05 AMBioNxt Solutions Inc.: BioNxt Reports on New Cladrabine ODF Product Development and Commercialization Programfinanznachrichten.de - November 16 at 9:02 AMBioNxt Reports on New Cladrabine ODF Product Development and Commercialization Programfinance.yahoo.com - November 15 at 7:33 AMBioNxt Signs Definitive Agreement For 100% Acquisition of IP And Co-Development of Cladribine ODF Drug Reformulation for The Treatment of Multiple Sclerosisfinance.yahoo.com - November 13 at 8:48 AMBioNxt Solutions berichtet über CPHI-Kongress in Barcelonabenzinga.com - November 6 at 6:26 PMBioNxt Solutions Reports on Barcelona CPHI Conferencefinance.yahoo.com - November 6 at 8:26 AMBioNxt Solutions Inc.: BioNxt Solutions Announces Closing of Third and Final Tranche of Non-Brokered Private Placementfinanznachrichten.de - October 27 at 7:56 PMBioNxt Solutions Announces Closing of Third and Final Tranche of Non-Brokered Private Placementfinance.yahoo.com - October 27 at 7:56 PMBioNxt Solutions Inc.: BioNxt Solutions Announces Change of Directorsfinanznachrichten.de - October 3 at 7:44 PMBioNxt Solutions Announces Change of Directorsfinance.yahoo.com - October 3 at 7:44 PMBioNxt Solutions Inc.: Bionxt Solutions Announces Closing of Second Tranche of Non-Brokered Private Placementfinanznachrichten.de - September 28 at 8:03 PMBionxt Solutions Announces Closing of Second Tranche of Non-Brokered Private Placementfinance.yahoo.com - September 28 at 8:03 PMBionxt Solutions Announces Closing of First Tranche of Non-Brokered Private Placementfinance.yahoo.com - August 28 at 6:49 PMBioNxt Solutions announces ~$4M private placementmsn.com - August 7 at 9:00 AMBioNxt Solutions Inc.: BioNxt Solutions Announces Non-Brokered Private Placementfinanznachrichten.de - August 4 at 8:51 PMBioNxt Signs LOI for Acquisition of IP and Co-Development of ODF Drug Reformulation for Neurodegenerative Diseasebenzinga.com - August 2 at 5:16 AMBioNxt Receives Approval for European Clinical Study of Transdermal Rotigotine Patch for Parkinson’s Diseasefinance.yahoo.com - July 3 at 12:57 PMBioNxt Receives Approval for European Clinical Study of Transdermal Rotigotine Patch for Parkinson's Diseasebenzinga.com - May 15 at 8:53 AMBioNxt Solutions Inc (BNXT)investing.com - May 10 at 10:30 AMBioNxt Successfully Completes Pilot Study for Contract Development Customermarketwatch.com - May 10 at 12:08 AMBioNxt Secures Contract to Develop and Manufacture ODF Product for International Pharmaceutical Companymarketwatch.com - April 24 at 7:27 PMBioNxt buys state-of-the-art coating and cutting equipment to build out European commercial manufacturing capacitymsn.com - April 18 at 12:15 PMBioNxt Acquires Commercial Coating and Cutting Equipment to Build Out European Commercial Manufacturing Capacitybenzinga.com - April 17 at 10:01 AMBioNxt Reports on Enteric Coating Drug Delivery Programbenzinga.com - April 15 at 1:51 AMBioNxt Solutions Inc.: BioNxt Solutions Announces Closing of Non-Brokered Private Placement and Grant of Stock Optionsfinanznachrichten.de - April 4 at 2:07 AMBioNxt Solutions Announces Closing of Non-Brokered Private Placement and Grant of Stock Optionsbenzinga.com - April 4 at 12:43 AMBioNxt Solutions Inc.: BioNxt Solutions Closes First Tranche of Financingfinanznachrichten.de - March 28 at 2:09 AMBioNxt Solutions Closes First Tranche of Financingfinance.yahoo.com - March 28 at 2:09 AMBionxt Solutions Announces Non-Brokered Private Placementbenzinga.com - March 10 at 4:18 PMBioNxt Solutions Inc.: BioNxt Solutions Acquires Novel Precision Drug Coating and Delivery Technologyfinanznachrichten.de - March 8 at 3:43 PMBioNxt Solutions Acquires Novel Precision Drug Coating and Delivery Technologyfinance.yahoo.com - March 8 at 3:43 PMBioNxt Solutions Inc.: BioNxt Solutions Announces Engagement Of Canaccord For Early Warrant Exercise Programfinanznachrichten.de - March 4 at 10:41 PMBioNxt Reports Update on Commercialization of Rotigotine Patch for Treatment of Parkinson's Diseaseyahoo.com - February 13 at 11:03 AM Get BioNxt Solutions News Delivered to You Automatically Sign up to receive the latest news and ratings for BNXTF and its competitors with MarketBeat's FREE daily newsletter. Email Address Automatic Income (from home) (Ad)For over 22 years, Wall Street elites have kept this little-known "income hack" from everyday investors… 6 simple clicks have set up HUGE payouts for "in-the-know" investors… Delivering them passive income 365 days a year. Just click here now to watch my presentation for free. BNXTF Media Mentions By Week BNXTF Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BNXTF News Sentiment▼0.680.40▲Average Medical News Sentiment BNXTF News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BNXTF Articles This Week▼00▲BNXTF Articles Average Week Get BioNxt Solutions News Delivered to You Automatically Sign up to receive the latest news and ratings for BNXTF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: INAB News NUTX News VIRX News POCI News VYNE News CASI News ECOR News THTX News ACXP News TARA News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:BNXTF) was last updated on 5/3/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyUrgent Nvidia WarningAltimetryAutomatic Income (from home)Awesomely, LLCCould Your Accounts Be Frozen?Allegiance GoldThe Gold Grab of the CenturyColonial MetalsThe A.I. story nobody is telling you (Read ASAP)TradeSmithREAD THIS – If You Missed Out On The AI BoomBanyan Hill PublishingDid You Get Your Free Bitcoin Yet?Crypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioNxt Solutions Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
